Breaking News

Intellipharmaceutics Augments Rexista Abuse-deterrence Technology

PODRAS platform technology aims to prevent overdose

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Intellipharmaceutics International, Inc. has released a new platform technology, PODRAS (Paradoxical OverDose Resistance Activating System), an enhanced version of its Rexista abuse-deterrence technologies designed to prevent overdose when more pills than prescribed are swallowed intact.   The company’s most advanced application of the PODRAS platform is currently its Rexista product candidate (oxycodone hydrochloride extended-release tablet), which is designed to deter abuse by both physical in...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters